Raia Drogasil S.A. (OTCMKTS:RADLY) Shares Shorted: Short Interest Down 40.3% in October

Raia Drogasil S.A. (OTCMKTS:RADLY) was the recipient of a significant drop in short interest in the month of October. As of October 15th, there was short interest totaling 793 shares, a drop of 40.3% from the September 30th total of 1,328 shares. Based on an average trading volume of 349,085 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the company’s stock are sold short.

Raia Drogasil Stock Down 3.2%

OTCMKTS:RADLY traded down $0.09 during trading hours on Friday, hitting $2.76. 4,628 shares of the company traded hands, compared to its average volume of 186,223. The company has a quick ratio of 0.58, a current ratio of 1.41 and a debt-to-equity ratio of 0.99. The firm’s 50-day simple moving average is $3.75 and its 200-day simple moving average is $4.08. Raia Drogasil has a one year low of $2.74 and a one year high of $5.34. The company has a market cap of $3.63 billion and a PE ratio of 18.40.

Raia Drogasil (OTCMKTS:RADLY) last posted its earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.05. The firm had revenue of $2.17 billion during the quarter, compared to analyst estimates of $2.32 billion. Raia Drogasil had a net margin of 2.99% and a return on equity of 20.12%. Equities analysts predict that Raia Drogasil will post 0.17 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group upgraded Raia Drogasil to a “buy” rating and set a $5.20 price objective for the company in a report on Sunday, October 18th. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, Raia Drogasil has a consensus rating of “Moderate Buy” and a consensus target price of $5.20.

Raia Drogasil Company Profile

Raia Drogasil, now operating under the name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a network of pharmacies offering prescription medicines, over-the-counter drugs, vitamins, personal care products, beauty items and other health-related merchandise.

The company also provides digital purchasing and delivery services through its online channels, supporting customers with prescription fulfillment, health products and related services. Its operations include pharmacy-based healthcare initiatives designed to complement its retail business and improve access to everyday healthcare.

RD Saúde was created in 2011 through the merger of Drogasil and Droga Raia, two established Brazilian pharmacy chains.